Logo new.jpg
VISLINK TECHNOLOGIES, INC. PRICES $6,000,000 PUBLIC OFFERING
February 12, 2020 08:30 ET | Vislink Technologies, Inc.
NEW YORK, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”)(Nasdaq: VISL), today announced the pricing of an underwritten public offering with expected total...
logo.png
Corbus Pharmaceuticals Announces Closing of $46 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
February 11, 2020 16:01 ET | Corbus Pharmaceuticals Holdings, Inc.
Norwood, MA, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative...
misonix.jpg
Misonix Announces Public Offering of Common Stock
January 22, 2020 16:01 ET | MISONIX, Inc.
FARMINGDALE, N.Y., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
ASLAN Pharmaceuticals Announces Pricing of $12.8 Million Public Offering of American Depositary Shares
December 03, 2019 01:00 ET | ASLAN PHARMACEUTICALS LIMITED
SINGAPORE, Dec. 03, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Limited (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that it has...
Logo.png
Guardion Health Sciences Announces Pricing of $8.4 Million Underwritten Public Offering
October 28, 2019 09:21 ET | Guardion Health Sciences, Inc.
San Diego, CA, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), announced the pricing of an underwritten public offering of 24,500,000...
REEDS_CorpTagline_Color_300.png
Reed’s Inc. Announces Proposed Public Offering of Common Stock
October 22, 2019 16:50 ET | Reeds, Inc.
NORWALK, Conn., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Reed’s Inc. (Nasdaq: REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, today announced that it intends to offer...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Pricing of its Public Offering
September 05, 2019 20:39 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Sept. 05, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Proposed Public Offering
September 04, 2019 16:02 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Sept. 04, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia Announces Pricing of $10.0 Million Public Offering and Uplisting to Nasdaq
August 02, 2019 09:45 ET | BioCardia, Inc.
SAN CARLOS, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NasdaqCM: BCDA, BCDAW), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
5b3fb0040fdcc50004b0c97d_1.png
Monaker Announces Proposed Public Offering of Common Stock
April 24, 2019 17:27 ET | Monaker Group, Inc
WESTON, FL, April 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Monaker Group, Inc. (MKGI: NASDAQ) today announced that it intends to offer newly issued shares of its common stock for sale in an...